Verification evidence is still being completed.
Human Biome Institute S.A.
Gdansk, Poland
- Verified lead
- Jaroslaw Bilinski
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Microbiome Biotherapeutics, Fecal Microbiota Transplantation, and Donor-Independent Microbiome Products
- Review cycle
- 24 April 2026
- Full address
- ul. Starodworska 1, 80-137 Gdansk, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Human Biome Institute team page naming Jaroslaw Bilinski as CEO.
- Editorial note
- Gdansk microbiome biotherapeutics company with named CEO, GMP FMT production via its Microbiota Center, and Polish MRA-funded clinical trials.
Microbiome Biotherapeutics, Fecal Microbiota Transplantation, and Donor-Independent Microbiome Products
GMP FMT production, Start-Up-Med 2022 recognition, Public CEO disclosure
Gdansk microbiome biotherapeutics company with named CEO, GMP FMT production via its Microbiota Center, and Polish MRA-funded clinical trials.
Human Biome Institute S.A.
Microbiome Biotherapeutics, Fecal Microbiota Transplantation, and Donor-Independent Microbiome Products · GMP FMT production and clinical development
Gdansk microbiome biotherapeutics company with named CEO, GMP FMT production via its Microbiota Center, and Polish MRA-funded clinical trials.
- Lead
- Jaroslaw Bilinski (verified ↗)
- Address
- ul. Starodworska 1, 80-137 Gdansk, Poland (source ↗)
- Compliance
- GMP FMT production
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- GMP FMT production and clinical development
- Capabilities
- Microbiota Center FMT Production · Clinical Trial Operations · Biosynthetic Microbiome Product Development
- Founded
- 2015
- Headcount
- 11-50
- Company page (open ↗)
Jaroslaw Bilinski
Chief Executive Officer
EMIS company profile listing Human Biome Institute at Starodworska 1 in Gdansk.
Open sourceGMP FMT production and clinical development
Gdansk, Poland. Microbiome Biotherapeutics, Fecal Microbiota Transplantation, and Donor-Independent Microbiome Products. Review completed on 24 Apr 2026.
Polish Office for Registration of Medicinal Products, EMA, and FDA for future oversight
GMP FMT production, Start-Up-Med 2022 recognition, Public CEO disclosure
Microbiome Biotherapeutics, Fecal Microbiota Transplantation, and Donor-Independent Microbiome Products
Gdansk microbiome biotherapeutics company with named CEO, GMP FMT production via its Microbiota Center, and Polish MRA-funded clinical trials.
Human Biome Institute anchors Polish microbiome therapeutics with a named CEO, an operating Microbiota Center for GMP FMT production, and Polish MRA-funded clinical trials.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Human Biome Institute S.A. located?
- Human Biome Institute S.A. operates from ul. Starodworska 1, 80-137 Gdansk, Poland, Gdansk, Poland.
- Who runs Human Biome Institute S.A.?
- Human Biome Institute S.A. is led by Jaroslaw Bilinski, Chief Executive Officer. Verified 24 Apr 2026.
- What certifications does Human Biome Institute S.A. hold?
- Human Biome Institute S.A. is documented under GMP FMT production.
- What does Human Biome Institute S.A. do?
- Gdansk microbiome biotherapeutics company with named CEO, GMP FMT production via its Microbiota Center, and Polish MRA-funded clinical trials. Core capabilities: Microbiota Center FMT Production, Clinical Trial Operations, Biosynthetic Microbiome Product Development.
Related technical briefs
Briefs that name Gdansk as a covered market or city.
